###  [:house:返回首頁](https://github.com/ourhimalayas/txt)
---

## 美国开始排干医药行业沼泽？临床试验数据造假被判罪
` Isaiah4031` [轉載自GNews](https://gnews.org/zh-hans/528453/)

美国司法部11月2日宣布，佛罗里达州一人因合谋伪造一种哮喘药物的临床试验数据而认罪。 司法部官员说说，“司法部会继续与食品和药物管理局（FDA）携手合作，调查和起诉那些把个人利益凌驾于公众健康之上的欺诈者。”

临床研究资料关系到新药的审批和上市，背后存在巨大的利益角逐，药品的上市背后可能存在不同程度的灰色地带。本次美国司法部的行动是否象征着开始着手排干医药行业的沼泽，让我们拭目以待。
![]()![](https://gnews-media-offload.s3.amazonaws.com/wp-content/uploads/2020/11/04155020/DOJ_20201102_conspiracy_falsify_clinical_trial_data_photo169.png)图片来源：[National Cancer Institute](https://unsplash.com/@nci?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText) on [Unsplash](https://unsplash.com/s/photos/clinical-trials?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText)
[阅读司法部英文原文](https://www.justice.gov/opa/pr/florida-resident-pleads-guilty-conspiracy-falsify-clinical-trial-data)

**Florida Resident Pleads Guilty to Conspiracy to Falsify Clinical Trial Data**

**佛罗里达居民承认共谋伪造临床试验资料**

FOR IMMEDIATE RELEASE

Monday, November 2, 2020

2020年11月2日即时公布

A Florida resident pleaded guilty to conspiring to falsify clinical trial data regarding an asthma medication, the Department of Justice announced today. The clinical trial was designed to investigate the safety and efficacy of an asthma medication in children between the ages of four and eleven.

(美国) 司法部今天宣布，一名佛罗里达州居民承认串谋伪造有关一种哮喘药物的临床试验资料。该临床试验旨在调查一种哮喘药物在4至11岁儿童中的安全性和有效性。

Lisett Raventos, 46, of Miami, Florida, pleaded guilty today in the U.S. District Court for the Southern District of Florida today to one count of conspiracy to commit wire fraud.  Raventos was the site director, the director of clinical operations, and a study coordinator at a medical clinic named Unlimited Medical Research (UM Research) in Miami, Florida.  In pleading guilty, Raventos admitted that from approximately 2013 to 2016, she participated in a scheme to defraud an unnamed pharmaceutical company by fabricating the data and participation of subjects in a clinical trial at UM Research.  The clinical trial was designed to investigate the safety and efficacy of an asthma medication in children between the ages of four and eleven. Raventos admitted that she falsified medical records to make it appear as though pediatric subjects made scheduled visits to UM Research, took study drugs as required, and received checks as payment.

来自佛罗里达州迈阿密的 46 岁的 Lisett Raventos 今天在美国佛罗里达州南区地方法院承认一项串谋进行电信欺诈的罪名。Raventos 是位于佛罗里达州迈阿密的一家名为无限医疗研究 (Unlimited Medical Research，UM Research) 的医疗诊所的主任、临床操作主任和研究协调员。在认罪中，Raventos 承认，大约在 2013 年至 2016 年期间，她参与了一项计划，通过伪造 UM Research 临床试验的资料和受试者的参与情况，欺骗一家未命名的制药公司, 该临床试验旨在调查一种哮喘药物在 4 至 11 岁儿童中的安全性和有效性。Raventos 承认，她伪造了医疗记录，使儿童受试者看起来像是按计划到 UM Research 就诊，按要求服用研究药物，并收到支票作为付款。

“Clinical trials help ensure that new drugs are safe and effective for the public, and this defendant undermined that process,” said Acting Assistant Attorney General Jeffrey Bossert Clark of the Justice Department’s Civil Division.  “The Department of Justice will continue to work hand-in-hand with the Food and Drug Administration (FDA) to investigate and prosecute fraudsters who put personal profit before public health.”

“临床试验有助于确保新药对公众安全有效，而这名被告破坏了这一过程，” 司法部民事部代理助理总检察长 Jeffrey Bossert Clark 说，“司法部会继续与食品和药物管理局（FDA）携手合作，调查和起诉那些把个人利益凌驾于公众健康之上的欺诈者。”

“Fraud in the conduct of clinical trials is simply unacceptable, especially where the drug under investigation was meant to serve children and other vulnerable populations,” said U.S. Attorney Ariana Fajardo Orshan for the Southern District of Florida.  “I thank our partners at the FDA’s Office of Criminal Investigations, Miami Field Office, for their work in investigating this scheme.”

“临床试验中的欺诈行为是完全不可接受的，特别是对于被调查的药物是为了服务于儿童和其他弱势群体的情况，” 佛罗里达州南部地区的美国检察官 Ariana Fajardo Orshan 说，“我感谢 FDA 迈阿密分局刑事调查办公室的合作伙伴，感谢他们为调查这一计划所做的工作。”

“Reliable clinical trial data is a foundation for FDA drug approval. Falsifying that data leaves consumers at risk of taking drugs that are neither safe nor effective,” said Special Agent in Charge Justin C. Fielder, FDA Office of Criminal Investigations Miami Field Office.  “We will continue to investigate and bring to justice those who endanger the public health when they engage in conduct that might subvert the FDA approval process.”

美国食品和药物管理局（FDA）刑事调查办公室迈阿密现场办公室特别负责人 Justin C. Fielder 说：“可靠的临床试验数据是 FDA 药物审批的基础。伪造这些数据会使消费者面临服用既不安全也非有效的药物的风险。”， “我们将继续调查那些危害公众健康的人，并将他们绳之以法，因为他们的行为可能破坏 FDA 的审批程序。”

Raventos pleaded guilty before U.S. District Judge Beth Bloom. Raventos is the first defendant to plead guilty in connection with the scheme.  Three other defendants were charged along with Raventos, and they are presumed innocent until proven guilty beyond a reasonable doubt. When sentenced, Raventos faces a maximum penalty of up to 20 years in prison.

Raventos 在美国地区法官 Beth Bloom 面前认罪。Raventos 是第一个承认与该阴谋有关的被告。和 Raventos 一起被起诉的还有其他三名被告，在排除合理怀疑证明有罪之前，他们被假定无罪。一旦被判刑，Raventos 将面临最高 20 年的监禁。

Assistant Director Clint L. Narver and Trial Attorneys Joshua Rothman, Jocelyn Hines, and Kara M. Traster of the Department of Justice’s Consumer Protection Branch are prosecuting the case.  The U.S. Food and Drug Administration’s Office of Criminal Investigations, Miami Field Office, investigated the case, and the U.S. Attorney’s Office of the Southern District of Florida has provided critical assistance.

司法部消费者保障部副部长 Clint L. Narver 和出庭律师 Joshua Rothman、Jocelyn Hines 和 Kara M. Traster 正在起诉此案。(美国)食品和药物管理局的犯罪调查办公室，迈阿密外勤办公室调查了此案，美国佛罗里达州南区检察官办公室提供了关键的援助。
![]()![](https://gnews-media-offload.s3.amazonaws.com/wp-content/uploads/2020/10/01001426/DOJ.jpeg)
翻译【Naomi】校对【重生】编辑【Isaiah4031】

战友之家玫瑰园小队出品
![]()![](https://gnews-media-offload.s3.amazonaws.com/wp-content/uploads/2020/11/01145114/GNEWS-GTV-VOG.png)
1+
